摘要
目的探讨终末期肺癌患者的抗感染治疗。方法对近3年来我院收治的127例终末期肺癌患者临床表现、合并肺部感染及抗菌药物应用和获益等情况进行回顾性分析。结果 127例终末期肺癌患者中合并肺部感染者112例(88.2%),其中103例(81.1%)患者给予抗感染治疗后症状均未改善,且均于1个月内死亡。结论终末期肺癌患者合并感染率高,抗菌药物应用品种广泛,但效果差。
Objective To investigate the incidence of terminal lung cancer patients with lung infection and anti-infection treatment.Methods To retrospectively analyze the clinical cases of 127 patients of terminal lung cancer with pulmonary infection and antimicrobial drug used in our hospital for the past three years.Results In the 127 cases of terminal lung cancer patients with pulmonary infection in 112 cases（88.2%）,of which 103 patients（81.1%） who died within 1 month were given anti-infection treatment,all patients were not meet clinical symptoms improved.Conclusion Terminal lung cancer patients are with a high proportion of lung infection,antibiotics are widely used,and there is abuse.
出处
《实用癌症杂志》
2012年第4期392-393,共2页
The Practical Journal of Cancer
关键词
原发性肺癌
终末期
肺部感染
抗感染治疗
Lung cancer
Terminal illness
Pulmonary infection
Anti-infection treatment
